April 3, 2007 - Maquet Inc. has announced the FDA approval of two new products for its Servo-i platform, the MR-conditional option and the Neurally Adjusted Ventilator Assist (NAVA), a new mode of mechanical ventilation.
The MR Conditional option for the Servo-i series provides use of the ventilator in the MRI environment and is approved for 1.0, 1.5 and 3.0 Tesla MR units.
NAVA uses diaphragmatic electrical activity, neural inspiration and expiration triggering as a means of improved ventilation support. With this new concept, the patient's respiratory center controls the mechanical support provided.
April 09, 2026 
